ALPS
Alps Group Inc
NASDAQ · Healthcare · Biotechnology · MY
$0.38
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 3.4M | 3.4M | 2.4M | 3.6M | — |
| Cost of Revenue | 2.1M | 2.1M | 1.8M | 1.6M | — |
| Gross Profit | 1.3M | 1.3M | 598.9K | 2.0M | — |
| Operating Expenses | |||||
| R&D Expense | — | — | 277.0K | — | — |
| SG&A Expense | 66.8M | 66.8M | 1.7M | 26.1M | 135.6K |
| General & Admin Expense | 66.8M | 66.8M | 1.5M | 26.1M | — |
| Selling & Marketing Expense | (904.5K) | — | 160.9K | — | — |
| Other Expenses | 1.4M | 1.4M | 973.4K | (23.6M) | — |
| Total Operating Expenses | 68.2M | 68.2M | 3.0M | 2.5M | 135.6K |
| Cost and Expenses | 70.2M | 70.2M | 4.8M | 4.1M | 135.6K |
| Operating Income (EBIT) | (66.8M) | (66.8M) | (2.4M) | (535.5K) | (135.6K) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | 99.00 |
| Interest Expense | 488.3K | 488.3K | 42.8K | 46.6K | — |
| Net Interest Income | (488.3K) | (488.3K) | (42.8K) | (46.6K) | 99.00 |
| Other Non-Op Income/Expense | (572.1K) | (572.1K) | (42.8K) | (46.6K) | 16.0K |
| Non-Operating Income (excl Interest) | 83.8K | 83.8K | — | — | (16.0K) |
| EBT (Pre-Tax Income) | (67.4M) | (67.4M) | (2.4M) | (582.1K) | (119.6K) |
| Income Tax Expense | 262.2K | 262.2K | (7.4K) | 147.8K | — |
| Bottom Line | |||||
| Net Income | (67.6M) | (67.6M) | (2.3M) | (729.2K) | (119.6K) |
| Earnings from Cont. Ops | (67.7M) | (67.7M) | (2.4M) | (729.9K) | (119.6K) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (67.6M) | (67.6M) | (2.3M) | (729.2K) | (119.6K) |
| Per Share | |||||
| Basic EPS | ($14.79) | ($14.64) | ($0.38) | ($0.02) | ($0.00) |
| Diluted EPS | ($14.79) | ($14.64) | ($0.38) | ($0.00) | ($0.00) |
| Revenue Per Share | $0.96 | $0.73 | $0.40 | $0.10 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 3.5M | 4.6M | 6.0M | 34.5M | 34.5M |
| Diluted Shares Outstanding | 3.5M | 4.6M | 6.0M | 53.6M | 53.6M |
| Profitability Metrics | |||||
| EBITDA | (66.9M) | (66.9M) | (1.5M) | 363.2K | (119.6K) |
| D&A | — | — | 903.4K | 898.6K | — |
| EBIT | (66.9M) | (66.9M) | (2.4M) | (535.5K) | (119.6K) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2025